Literature DB >> 2031621

Paediatric bone marrow transplantation using donors other than HLA genotypically identical siblings.

J M Hows1.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 2031621      PMCID: PMC1792994          DOI: 10.1136/adc.66.4.546

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  20 in total

1.  CD4+ T cells appear capable of initiating graft-versus-host disease across non-major histocompatibility complex (MHC) barriers in man.

Authors:  K Atkinson; M Cooley; H Farrelly; E O'Flaherty; M Ashby; J Biggs
Journal:  Bone Marrow Transplant       Date:  1987-06       Impact factor: 5.483

2.  An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

Authors:  J J Neefjes; B S Breur-Vriesendorp; G A van Seventer; P Iványi; H L Ploegh
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

3.  A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia.

Authors:  B M Camitta; E D Thomas; D G Nathan; R P Gale; K J Kopecky; J M Rappeport; G Santos; E C Gordon-Smith; R Storb
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

4.  Marrow transplantation from related donors other than HLA-identical siblings.

Authors:  P G Beatty; R A Clift; E M Mickelson; B B Nisperos; N Flournoy; P J Martin; J E Sanders; P Stewart; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

5.  Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

Authors:  J M Goldman; R P Gale; M M Horowitz; J C Biggs; R E Champlin; E Gluckman; R G Hoffmann; S J Jacobsen; A M Marmont; P B McGlave
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

6.  A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10.

Authors:  J L Bidwell; E A Bidwell; D A Savage; D Middleton; P T Klouda; B A Bradley
Journal:  Transplantation       Date:  1988-03       Impact factor: 4.939

7.  Growth and development following marrow transplantation for leukemia.

Authors:  J E Sanders; S Pritchard; P Mahoney; D Amos; C D Buckner; R P Witherspoon; H J Deeg; K C Doney; K M Sullivan; F R Appelbaum
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

8.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

Authors:  C Anasetti; D Amos; P G Beatty; F R Appelbaum; W Bensinger; C D Buckner; R Clift; K Doney; P J Martin; E Mickelson
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

9.  Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.

Authors:  G W Santos; P J Tutschka; R Brookmeyer; R Saral; W E Beschorner; W B Bias; H G Braine; W H Burns; G J Elfenbein; H Kaizer
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

10.  Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.

Authors:  A Fischer; C Griscelli; W Friedrich; B Kubanek; R Levinsky; G Morgan; J Vossen; G Wagemaker; P Landais
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

View more
  1 in total

1.  Who pioneered the use of alternative donors (and stem cells from peripheral blood) in bone marrow transplantation?

Authors:  K Hughes-Jones; S Selwyn; P G Riches
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.